ArticleFrontiers in psychiatry2024
Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for cannabis.
Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- High-frequency repetitive transcranial magnetic stimulation is associated with sustained improvement in cannabis use disorder: a one-year, two-phase, three-arm randomized study.Frontiers in psychiatry · 2026Trial
- Changes in drug-use behaviors among people who use drugs with comorbid psychiatric disorders across the COVID-19 pandemic: a three-phase longitudinal cohort study.Frontiers in public health · 2026Article
- Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for DSM-5 stimulant use disorder.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cannabis use and misuse are surging among the Chinese community in East and Southeast Asia. A quick screening instrument that can effectively identify users with dependence for early intervention is in utmost need. This study examined the psychometric properties of the Chinese version of the Severity of Dependence Scale for cannabis (C-SDS-C) in screening for the DSM-5 defined Cannabis Use Disorder (CUD). Methods: A retrospective chart review was conducted on Chinese-speaking individuals reporting cannabis use from three different substance use studies. Their demographic data, frequency of cannabis use within the past 30 days, scorings for the C-SDS-C and the severity of CUD at baseline were analyzed. Results: The C-SDS-C exhibited high reliability (Cronbach's alpha = 0.778). It had a strong correlation with the severity of CUD (r = 0.456, Conclusion: The C-SDS-C is a valid and reliable screening instrument to identify cannabis users with moderate-to-severe CUD in the Chinese-speaking population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.